Meningoencephalitis tuberculosis as a paradoxical response to anti-tuberculous therapy in a child with pulmonary tuberculosis - a case report
Abstract
This paper reports a case of meningoencephalitistuberculosis as a paradoxical response to anti-tubercu-
lous therapy in a child with pulmonary tuberculosis.
References
doxical worsening of tuberculosis following antiretroviral
therapy in patients with AIDS. Am J Respir Crit Care Med
1998; 158:156-61.
2. Karagoz T, Altinoz H, Senol T. Paradoxical response to an-
tituberculous therapy. Turkish Resp J 2003;4: 17-20.
3. Janmeja AK, Das SK. Cervico-mediastinallymphadenopathy
as a paradoxical response to chemotherapy in pulmonary
tuberculosis. Respiration 2003; 70:219-20.
4. Subhash HS, Supriya S, Prakash B, Thomas K. Acute respiratory
distress syndrome as paradoxical response to anti-tuberculosis
and anti-retroviral therapy. Indian J Tuberc 2006;53: 157-60.
5. Jain SK, Kwon P, Moss WJ. Management and outcomes of
intracranial tuberculomas developing during antituberculous
therapy: case report and review. Clin Pediatr 2005;44:443-50.
6. Navas E, Martin DP, Moreno L, Pintado V, Cassado JL, Fortun
J et al. Paradoxical reactions of tuberculosis in patients with the
acquired immunodeficiency syndrome who are treated with highly
active antiretroviral therapy. Arch Intern Med 2002; 162:97-9.
7. Orlovic D, Smego RA. Paradoxical tuberculous reactions in
HIV-infected patients. lnt J Tuberc Lung Dis 2001;5:370-5.
8. Lazarus A, Sanders J. Management of tuberculosis choosing
an effective regimen and ensuring compliance. Postgrad Med
2000;108:71-84.
9. Takayama K, Armstrong EL, Kunugi KA, KilburnJO. Inhibi-
tion by ethambutol of myolic acid transfer into the cell wall of
mycobacterium smegmatis. Antimicrob Agents Chemother
1979; 16:240-2.
10. YermaJ, SinghAK, Bhatnagar A, SenS, Bose M. Radio-label-
ling of ethambutol with technetium-99m and its evaluation for
detection of tuberculosis. World J Nucl Med 2005;4:35-46.
11. Das SS, Hall A V, Wareham DW, Britton KE. Infection imaging
with radiopharmaceuticals in the 21 ''century. Braz Arch Bioi
Technol v.45 n.spe Curitiba set. 2002.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Accepted 2016-09-12
Published 2016-09-15